Global Prostate Cancer Partnering Deals and Agreements by the World’s Leading Healthcare Companies 2010 to 2017 – Research and Markets

DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Global
Prostate Cancer Partnering 2010 to 2017″
report to their
offering.

The report provides understanding and access to the partnering deals and
agreements entered into by the world’s leading healthcare companies.

The report provides an analysis of partnering deals. The majority of
deals are discovery or development stage whereby the licensee obtains a
right or an option right to license the licensors technology. These
deals tend to be multicomponent, starting with collaborative R&D, and
commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated
deals terms provides critical insight into the negotiation process in
terms of what you can expect to achieve during the negotiation of terms.
Whilst many smaller companies will be seeking details of the payments
clauses, the devil is in the detail in terms of how payments are
triggered – contract documents provide this insight where press releases
do not.

Executive Summary:

– In-depth understanding of deal trends since 2010

– Access to headline, upfront, milestone and royalty data

– Comprehensive access to multiple deals entered into by the world’s
biopharma companies since 2010

– Insight into key deal terms included in contracts, where disclosed

– Understand the key deal terms companies have agreed in deals

– Undertake due diligence to assess suitability of your proposed deal
terms for partner companies

Key Topics Covered:

Executive Summary

1. Therapy partnering trends in numbers

2. Most active dealmakers

3. Partnering deals directory

4. Partnering deals with a contract document

5. M&A in numbers

6. M&A deals directory

7. Financing in numbers

8. Financing deals directory

For more information about this report visit http://www.researchandmarkets.com/research/z3ztvq/global_prostate

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related
Topics: Prostate
Cancer Drugs

Recibe gratis las noticias más importantes y más leídas diariamente en tu email

Este sitio está protegido por reCAPTCHA y Google Política de privacidad y Se aplican las Condiciones de servicio.

¡Muchas gracias!

Más sobre este tema
Contenido Patrocinado
Enlaces patrocinados por Outbrain